Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.

Oncologic Drugs Advisory Committee

July 24, 2007

Otis Brawley, M.D.

18 U.S.C. 208 waiver (pdf)
Acknowledgement and Consent (pdf)

John T. Farrar, M.D.

18 U.S.C. 208 waiver (pdf)
Acknowledgement and Consent (pdf)

David Harrington, Ph.D.

18 U.S.C. 208 waiver (pdf)
Acknowledgement and Consent (pdf)

Pamela Haylock, R.N., M.A.

Acknowledgement and Consent (pdf)

Maha Hussain, M.D.

Acknowledgement and Consent (pdf)

Michael Perry, M.D.

Acknowledgement and Consent (pdf)